# A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

> **NCT06836492** · PHASE3 · RECRUITING · sponsor: **Yizhuo Zhang** · enrollment: 300 (estimated)

## Conditions studied

- Rhabdomyosarcoma
- Pediatric Cancer

## Interventions

- **COMBINATION_PRODUCT:** VAC，VAC/VII，CAV/IE

## Key facts

- **NCT ID:** NCT06836492
- **Lead sponsor:** Yizhuo Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01-30
- **Primary completion:** 2029-09
- **Final completion:** 2029-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06836492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06836492, "A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06836492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*